We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

No Proven Links Between Eczema Drug, Cancer: Judge

Law360 (July 9, 2008, 12:00 AM EDT) -- A judge has granted summary judgment in favor of Novartis Pharmaceuticals Corp. in a suit that alleged the company's eczema drug Elidel causes lymphoma.

Judge Stewart Dalzell of the U.S. District Court for the Eastern District of Pennsylvania granted summary judgment Wednesday on the grounds that the plaintiffs' expert testimony was inadmissible because those experts failed to produce compelling evidence linking the drug's active ingredient, pimecrolimus, with the cancer.

The judge found “an analytical gap” between the data the two expert scientists produced “and the specific...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.